{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-016103","form_type":"8-K","ticker":"FRMM","cik":"0001690080","company_name":"FORUM MARKETS Inc","filed_at":"2025-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.456962+00:00","generated_at":"2026-05-26T06:59:24.210581+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"180 Life Sciences appoints Eric Van Lent as CAO; CEO Blair Jordan gets new contract with raise","bullets":["Eric Van Lent appointed Chief Accounting Officer (principal accounting/financial officer) effective Feb 15, 2025.","Blair Jordan steps down as principal accounting officer but remains CEO; new consulting agreement pays $240k/year plus 160,000 restricted shares.","EVL Consulting (Van Lent's firm) to be paid $8,000/month for 10 hrs/week; term through July 30, 2025.","Four non-executive directors each awarded 65,000 restricted shares, vesting 50% on July 1, 2025 and 50% on Dec 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-016103","json":"https://secwatch.observer/filing/0001213900-25-016103.json","markdown":"https://secwatch.observer/filing/0001213900-25-016103.md","text":"https://secwatch.observer/filing/0001213900-25-016103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1690080/000121390025016103/0001213900-25-016103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1690080/000121390025016103/ea0231758-8k_180life.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T06:59:24.210581+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"699f4daf66","claim":"Blair Jordan changed role as Principal Accounting/Financial Officer at FORUM MARKETS Inc.","evidence_excerpt":"As a result of the Appointment, Blair Jordan, the Chief Executive Officer (Principal Executive Officer) of the Company, who had served as the Principal Accounting/Financial Officer of the Company since October 16, 2024, stepped down from such role, also effective on February 15, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390025016103/0001213900-25-016103-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Principal Accounting/Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"aa6fc8ce15","claim":"Eric R. Van Lent was appointed as Chief Accounting Officer at FORUM MARKETS Inc.","evidence_excerpt":"Effective on February 15, 2025, the Board of Directors of 180 Life Sciences Corp. (the “ Company ”, “ we ” and “ us ”), appointed Eric R. Van Lent as the Chief Accounting Officer (Principal Accounting/Financial Officer) of the Company (the “ Appointment ”), which Appointment was effective as of the same date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1690080/000121390025016103/0001213900-25-016103-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}